These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34265314)

  • 41. Can you score with balloons to enhance outcomes after drug coated balloon angioplasty? Insights from the Paris DCB Registry for in-stent restenosis.
    Merat B; Waliszewski M; Dillinger G; Henry P; Sideris G
    J Interv Cardiol; 2018 Jun; 31(3):353-359. PubMed ID: 29527716
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neointima characteristics as a prognostic marker for drug-coated balloon angioplasty in patients with in-stent restenosis: an optical coherence tomography study.
    Kim HO; Jung HW; Lee JH; Kim JS; Hong SJ; Ahn CM; Kim BK; Kim W; Kim SJ; Kim W; Ko YG; Choi D; Hong MK; Jang Y
    Coron Artery Dis; 2020 Dec; 31(8):694-702. PubMed ID: 32976245
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term clinical safety and efficacy of drug-coated balloon in the treatment of in-stent restenosis: A meta-analysis and systematic review.
    Xi Y; Chen J; Bi Y; Xie S; Liao T; Zhang Y; Kislauskis E; Wu T; Laham R; Xiao J
    Catheter Cardiovasc Interv; 2020 Aug; 96(2):E129-E141. PubMed ID: 31714010
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effectiveness of excimer laser coronary atherectomy with contrast medium for underexpanded stent: The findings of optical frequency domain imaging.
    Ashikaga T; Yoshikawa S; Isobe M
    Catheter Cardiovasc Interv; 2015 Nov; 86(5):946-9. PubMed ID: 25754354
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).
    Rittger H; Waliszewski M; Brachmann J; Hohenforst-Schmidt W; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Schlundt C; Zimmermann S; Lonke S; von Cranach M; Markovic S; Daniel WG; Achenbach S; Wöhrle J
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1695-700. PubMed ID: 26476609
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Simple balloon dilation for drug-eluting in-stent restenosis: an optical coherent tomography analysis.
    Arikawa R; Yamaguchi H; Takaoka J; Miyamura A; Atsuchi N; Ninomiya T; Atsuchi Y; Ohishi M; Terashima M; Kaneda H
    Cardiovasc Revasc Med; 2015; 16(1):27-31. PubMed ID: 25578507
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differences in clinical outcomes between pre- and post-marketing clinical study following paclitaxel-coated balloon catheter treatment for coronary in-stent restenosis: from the Japanese regulatory viewpoint.
    Mitsutake Y; Konishi A; Shiba T; Ito T; Ho M; Shirato H
    Heart Vessels; 2021 Feb; 36(2):155-162. PubMed ID: 32776235
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Optical Coherence Tomography Predictors for Recurrent Restenosis After Paclitaxel-Coated Balloon Angioplasty for Drug-Eluting Stent Restenosis.
    Miura K; Tada T; Habara S; Kuwayama A; Shimada T; Ohya M; Murai R; Amano H; Kubo S; Otsuru S; Tanaka H; Fuku Y; Goto T; Kadota K
    Circ J; 2018 Oct; 82(11):2820-2828. PubMed ID: 30158345
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of in-stent coronary restenosis with excimer laser angioplasty.
    Liu M; Chow WH; Kwok OH; Jim MH; Yip A; Fan K; Chan E
    Chin Med J (Engl); 2000 Jan; 113(1):14-7. PubMed ID: 11775201
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Benefits of excimer laser coronary angioplasty over thrombus aspiration therapy for patients with acute coronary syndrome and thrombolysis in myocardial infarction flow grade 0.
    Arai T; Tsuchiyama T; Inagaki D; Yoshida K; Fukamizu S
    Lasers Med Sci; 2022 Dec; 38(1):13. PubMed ID: 36542184
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neointimal Modification With Scoring Balloon and Efficacy of Drug-Coated Balloon Therapy in Patients With Restenosis in Drug-Eluting Coronary Stents: A Randomized Controlled Trial.
    Kufner S; Joner M; Schneider S; Tölg R; Zrenner B; Repp J; Starkmann A; Xhepa E; Ibrahim T; Cassese S; Fusaro M; Ott I; Hengstenberg C; Schunkert H; Abdel-Wahab M; Laugwitz KL; Kastrati A; Byrne RA;
    JACC Cardiovasc Interv; 2017 Jul; 10(13):1332-1340. PubMed ID: 28683939
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Late Restenosis After Paclitaxel-Coated Balloon Angioplasty Occurs in Patients With Drug-Eluting Stent Restenosis.
    Habara S; Kadota K; Shimada T; Ohya M; Amano H; Izawa Y; Kubo S; Hyodo Y; Otsuru S; Hasegawa D; Tada T; Tanaka H; Fuku Y; Goto T; Mitsudo K
    J Am Coll Cardiol; 2015 Jul; 66(1):14-22. PubMed ID: 26139053
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systematic Scoring Balloon Lesion Preparation for Drug-Coated Balloon Angioplasty in Clinical Routine: Results of the PASSWORD Observational Study.
    Bonaventura K; Schwefer M; Yusof AKM; Waliszewski M; Krackhardt F; Steen P; Ocaranza R; Zuhdi AS; Bang LH; Graf K; Böck U; Chin K
    Adv Ther; 2020 May; 37(5):2210-2223. PubMed ID: 32274746
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Complex, high-risk, and indicated percutaneous coronary angioplasty in essentially calcified stented coronary lesions using excimer laser coronary atherectomy with contrast mix injection.
    Wacinski P; Madejczyk A; Kondracki B; O'Kane P; Wacinski J; Kijewski B; Kawiak A; Binko P; Głowniak A; Wysokiński A
    Postepy Kardiol Interwencyjnej; 2023 Sep; 19(3):209-216. PubMed ID: 37854964
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Drug-Coated Balloons Versus Second-Generation Drug-Eluting Stents for the Management of Recurrent Multimetal-Layered In-Stent Restenosis.
    Kawamoto H; Ruparelia N; Latib A; Miyazaki T; Sato K; Mangieri A; Contri R; Stella S; Figini F; Chieffo A; Carlino M; Montorfano M; Colombo A
    JACC Cardiovasc Interv; 2015 Oct; 8(12):1586-94. PubMed ID: 26386758
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of drug-coated balloon angioplasty after directional coronary atherectomy for coronary bifurcation lesions (DCA/DCB registry).
    Kitani S; Igarashi Y; Tsuchikane E; Nakamura S; Seino Y; Habara M; Takeda Y; Shimoji K; Yasaka Y; Kijima M
    Catheter Cardiovasc Interv; 2021 Apr; 97(5):E614-E623. PubMed ID: 32776689
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A comparison between drug-eluting stent implantation and drug-coated balloon angioplasty in patients with left main bifurcation in-stent restenotic lesions.
    Kook H; Joo HJ; Park JH; Hong SJ; Yu CW; Lim DS
    BMC Cardiovasc Disord; 2020 Feb; 20(1):83. PubMed ID: 32070287
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Turbo-Power™ Laser Atherectomy Combined with Drug-coated Balloon Angioplasty is Associated with Improved One-Year Outcomes for the Treatment of Tosaka II and III Femoropopliteal In-stent Restenosis.
    Giannopoulos S; Kokkinidis DG; Jawaid O; Behan S; Hossain P; Alvandi B; Foley TR; Singh GD; Waldo SW; Armstrong EJ
    Cardiovasc Revasc Med; 2020 Jun; 21(6):771-778. PubMed ID: 31761634
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment strategies for in-stent restenosis in peripheral arterial disease: a systematic review.
    Hajibandeh S; Hajibandeh S; Antoniou SA; Torella F; Antoniou GA
    Interact Cardiovasc Thorac Surg; 2019 Feb; 28(2):253-261. PubMed ID: 30052955
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Second-generation drug-eluting stents versus drug-coated balloons for the treatment of coronary in-stent restenosis: A systematic review and meta-analysis.
    Kokkinidis DG; Prouse AF; Avner SJ; Lee JM; Waldo SW; Armstrong EJ
    Catheter Cardiovasc Interv; 2018 Aug; 92(2):285-299. PubMed ID: 29024274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.